Literature DB >> 11086640

Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men.

E Näslund1, I Andersson, M Degerblad, P Kogner, J G Kral, S Rössner, P M Hellström.   

Abstract

OBJECTIVE: The aim of the present study was to identify predictors of weight loss in obese men participating in a 2-year behaviour modification programme.
DESIGN: Longitudinal, clinical intervention study of a behaviour modifying weight loss program.
SETTING: University Hospital, Stockholm, Sweden.
SUBJECTS: Forty-four obese men (age, 42.7 +/- 1.1 years: BMI, 37.1 +/- 0.6 kg m(-2), mean +/- SEM) followed for 2 years.
INTERVENTIONS: Behaviour modification weight loss programme. MAIN OUTCOME MEASURES: Associations between plasma leptin and thyroid function tests, insulin resistance by homeostatic model assessment (HOMA), dietary recall and anthropometrically determined body composition.
RESULTS: At baseline, there were significant correlations between plasma leptin and body mass index (BMI), fat-free mass (FFM) and insulin resistance. Median weight loss over 2 years was 4.9 kg (range, -27.2 to +11.9). Baseline serum leptin concentrations adjusted for BMI (leptin/BMI ratio) were significantly correlated with 2-year weight change (r = 0.34, P = 0.04). A subset of seven of the 44 men gained weight over the 2 years. These 'gainers' differed significantly in initial leptin/BMI ratio (0.62 +/- 0.07) compared with the 37 'losers' (0.42 +/- 0.03, P < 0.05). In a multiple regression model, baseline leptin, insulin and age predicted 22% of the variance in weight change with no additional significant contribution from BMI, FFM, waist:hip ratio, thyroid function tests or energy intake. There was a strong correlation between the change in leptin concentrations and the change in insulin resistance from baseline to 2-year follow-up (r = 0.54; P < 0.001).
CONCLUSION: Baseline plasma leptin concentrations predicted long-term weight loss. Inappropriate leptin secretion or disposal, corrected for BMI, was associated with failure to maintain weight loss in obese men in a behaviour modification weight loss programme.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086640     DOI: 10.1046/j.1365-2796.2000.00737.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  13 in total

1.  Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects.

Authors:  Rochelle Goldsmith; Denis R Joanisse; Dympna Gallagher; Katherine Pavlovich; Elisabeth Shamoon; Rudolph L Leibel; Michael Rosenbaum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-04       Impact factor: 3.619

Review 2.  The role of leptin in obesity and the potential for leptin replacement therapy.

Authors:  Helin Feng; Lihua Zheng; Zhangying Feng; Yaheng Zhao; Ning Zhang
Journal:  Endocrine       Date:  2012-12-29       Impact factor: 3.633

3.  Iodine deficiency is higher in morbid obesity in comparison with late after bariatric surgery and non-obese women.

Authors:  Albert Lecube; Carles Zafon; Adoración Gromaz; José Manuel Fort; Enric Caubet; Juan Antonio Baena; Frederic Tortosa
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

4.  Changes in lifestyle improve body composition, thyroid function, and structure in obese children.

Authors:  G Radetti; S Longhi; M Baiocchi; W Cassar; F Buzi
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

5.  The relationship between hyperthyrotropinemia and metabolic and cardiovascular risk factors in a large group of overweight and obese children and adolescents.

Authors:  G Radetti; G Grugni; F Lupi; N Marazzi; S Longhi; A Fanolla; A Sartorio
Journal:  J Endocrinol Invest       Date:  2017-06-05       Impact factor: 4.256

6.  Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit.

Authors:  Lucyna Kozłowska; Danuta Rosołowska-Huszcz
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

Review 7.  Thyroid function and obesity.

Authors:  Silvia Longhi; Giorgio Radetti
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-11-01

8.  Relation with HOMA-IR and thyroid hormones in obese Turkish women with metabolic syndrome.

Authors:  S Topsakal; E Yerlikaya; F Akin; B Kaptanoglu; T Erürker
Journal:  Eat Weight Disord       Date:  2012-03       Impact factor: 3.008

9.  Triiodothyronine increases mRNA and protein leptin levels in short time in 3T3-L1 adipocytes by PI3K pathway activation.

Authors:  Miriane de Oliveira; Renata de Azevedo Melo Luvizotto; Regiane Marques Castro Olimpio; Maria Teresa De Sibio; Sandro José Conde; Carolina Biz Rodrigues Silva; Fernanda Cristina Fontes Moretto; Célia Regina Nogueira
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

10.  Triiodothyronine modulates the expression of leptin and adiponectin in 3T3-L1 adipocytes.

Authors:  Miriane de Oliveira; Maria Teresa de Síbio; Regiane Marques Castro Olimpio; Fernanda Cristina Fontes Moretto; Renata de Azevedo Melo Luvizotto; Celia Regina Nogueira
Journal:  Einstein (Sao Paulo)       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.